Treatment of Recurrent/Metastatic Head and Neck Cancer
Clinical trial NCT07601204 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07601204
- Sponsor
- Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-01
- Primary completion
- 2029-02-01
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.